4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-22-016440
Interim CEO, COO & CFO acquired 175,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LOWE CHRISTOPHER P. Interim CEO, COO & CFO | 2022-03-03 | Grant or award | +175,000 | 265,000 | D |
Loading xslF345X03/doc4.xml…